Symptoms
Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
Nasal swab offers hope for reducing vancomycin use
A study has found a pharmacy-driven protocol using nasal swabs to assess methicillin‑resistant Staphylococcus aureus (MRSA) in pneumonia cases holds promise for reducing unnecessary...
Q&A: Federal Assistant Minister for Health David Gillespie
Australian Pharmacist spoke with Dr David Gillespie MP, the Federal Assistant Minister for Health, about his experiences and engagements with pharmacists during his medical...
Caring for our elders
This Royal Commission is an opportunity to improve how we care for our elderly, and release the chains holding pharmacists back from preventing inappropriate...
Overprescribing of psychotropics for adults with autism
Adults on the autism spectrum are often prescribed psychotropic medication to manage behaviour, despite limited evidence to support this practice, a new report has...
Prenatal vitamin D for schizophrenia
The genetic and environmental factors behind schizophrenia are poorly understood, but research is increasingly finding links between maternal vitamin D status and the risk...
